Nanjing Jiuxiao Pharmaceutical

Nanjing Jiuxiao Pharmaceutical is a specialized biotechnology company based in Nanjing, China, focusing on the development of innovative transdermal drug delivery systems. The company's core expertise lies in its proprietary dissolvable microneedle technology, which allows for the painless administration of therapeutics that typically require injections. Their platform is designed to enhance the stability and delivery efficiency of sensitive biologics, including vaccines and peptides like insulin. By replacing traditional needles with self-administered patches, the company aims to improve patient compliance and reduce medical waste. Nanjing Jiuxiao is currently advancing a pipeline that targets high-prevalence conditions such as diabetes, infectious diseases, and localized pain management.